Zhejiang Tailin Bioengineering Co Ltd - Asset Resilience Ratio
Zhejiang Tailin Bioengineering Co Ltd (300813) has an Asset Resilience Ratio of 8.46% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Zhejiang Tailin Bioengineering Co Ltd (300813) strategic investment index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how Zhejiang Tailin Bioengineering Co Ltd's Asset Resilience Ratio has changed over time. See net asset quality index of Zhejiang Tailin Bioengineering Co Ltd to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Tailin Bioengineering Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300813 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥80.10 Million | 8.46% |
| Total Liquid Assets | CN¥80.10 Million | 8.46% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Tailin Bioengineering Co Ltd maintains only 8.46% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Tailin Bioengineering Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Tailin Bioengineering Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Zhejiang Tailin Bioengineering Co Ltd (2021–2025)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Tailin Bioengineering Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 19.13% | CN¥183.51 Million ≈ $26.85 Million |
CN¥959.34 Million ≈ $140.38 Million |
+16.07pp |
| 2021-12-31 | 3.06% | CN¥20.05 Million ≈ $2.93 Million |
CN¥655.87 Million ≈ $95.97 Million |
-- |
About Zhejiang Tailin Bioengineering Co Ltd
Zhejiang Tailin BioEngineering Co.,Ltd research and development, production, and sells microbial detection, contamination control, process analysis, and inhibition protection in the life sciences field in China and internationally. It primarily provides aseptic production and contamination control equipment, microbial testing products, and organic matter analysis technology products. The company … Read more